PARAMOUNT GOLD NEVADA CORP (PZG)

US69924M1099 - Common Stock

0.2895  +0 (+0.24%)

After market: 0.3 +0.01 (+3.63%)


Fundamental Rating

3

Overall PZG gets a fundamental rating of 3 out of 10. We evaluated PZG against 954 industry peers in the Metals & Mining industry. Both the profitability and financial health of PZG have multiple concerns. PZG shows excellent growth, but is valued quite expensive already.

Note: PZG has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

PZG has a Piotroski-F score of 4.00. This indicates an average health and profitability for PZG.

VS Industry

Valuation

Valuation Rating

3

When comparing the current price to the book value of PZG, it is valued rather cheaply. It is trading at 0.33 times its book value.
Compared to an average industry price book ratio of 1.54, PZG is valued rather cheaply. On top of this, PZG is cheaper than 94% of the companies listed in the same industry.

The Price/Earnings Ratio is negative for PZG. In the last year negative earnings were reported.
Also next year PZG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
VS Industry

Price/Book (0.33) VS Industry: 94% outperformed.

200.30
0.03

Growth

Growth Rating

7

The Earnings Per Share has grown by an impressive 26.48% over the past year.
PZG is expected to show a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 22.47% yearly.

Looking at the last year, PZG shows a very strong growth in Revenue. The Revenue has grown by 36.09%.
The Revenue has been growing slightly by 3.35% on average over the past 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 26.48% 55.56% 22.47% N/A N/A
Revenue3.35% -6.15% 36.09% N/A N/A N/A N/A

Health

Health Rating

1

The Debt to Equity ratio of PZG is in line with the industry averages.
The Piotroski-F score of PZG is 4.00. This is a neutral score and indicates average health and profitability for PZG.
PZG has a Current Ratio of 0.34. This is a bad value and indicates that PZG is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Current Ratio of 2.57, PZG is worse placed to pay its short term obligations than its industry peers. 88% of its industry peers have a better Current Ratio.

PZG has a Quick Ratio of 0.34. This is a bad value and indicates that PZG is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Quick Ratio of 2.11, PZG is worse placed to pay its short term obligations than its industry peers. 86% of its industry peers have a better Quick Ratio.
Based on the Altman-Z score of -1.45, we must say that PZG is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of PZG to the average industry Altman-Z score of 2.29, PZG is less financially healthy than its industry peers.
VS Industry

Debt/Equity (0) VS Industry: 53% outperformed.

9.62
0.00

Quick Ratio (0.34) VS Industry: 14% outperformed.

0.00
178.59

Current Ratio (0.34) VS Industry: 12% outperformed.

0.00
178.59

Altman-Z (-1.45) VS Industry: 26% outperformed.

-2,971.54
2,514.55

Dividend

Dividend Rating

0

PZG does not give a dividend.

PARAMOUNT GOLD NEVADA CORP

NYSEARCA:PZG (5/26/2023, 7:04:01 PM)

After market: 0.3 +0.01 (+3.63%)

0.2895

+0 (+0.24%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-10 2023-02-10/amc
Earnings (Next)N/A N/A
Inst Owners6.46%
Inst Owner Change-3.71%
Ins Owners20.13%
Ins Owner Change46.51%
Market Cap14.45M
Analysts80
Price Target1.53 (428.5%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)-73.27%
Min EPS beat(2)-98.02%
Max EPS beat(2)-48.51%
EPS beat(4)1
Avg EPS beat(4)-43.8%
Min EPS beat(4)-98.02%
Max EPS beat(4)15.13%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 55.38
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.33
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.01
BVpS0.87
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM N/A
ROICexgc(3y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc(3y)N/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2972.97%
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z -1.45
F-Score4
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)1956.5%
Cap/Depr(5y)14042.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y26.48%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q57.14%
EPS Next Y55.56%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue growth 1Y36.09%
Revenue growth 3Y-6.15%
Revenue growth 5Y3.35%
Revenue growth Q2QN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-26.15%
OCF growth 3YN/A
OCF growth 5YN/A
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA